GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...

A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...

Former President Joe Biden, in his first public address since finishing prostate cancer treatment, urged “optimism” in a time ...

Prostate cancer survivors Mark V. Williamson and Jim East will celebrate with other men who beat the disease, Nov. 16 at the ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

Researchers from UCLA have found a promising new way to help men with recurring prostate cancer live longer without their ...

Scientists at Columbia University have discovered that metformin, a common and inexpensive diabetes drug, may help treat ...

A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

Prostate cancer is the second most common cancer diagnosis in men. 1 in 8 men will be diagnosed with the disease during their ...